Drug Supply Assessment (Q1 2021): Philadelphia, Pennsylvania, USA

Public Health Alerts

The CFSRE is developing Public Health Alerts and related reports to increase public awareness regarding NPS involvement in adverse intoxications, mass overdoses, and fatalities. These reports are generated based on subsets of data collected at or near the time of first report or incidence and may not necessarily reflect all results for a specific emerging NPS.

EAD LogoTaking too long?
Reload Reload document
| Open Open in new tab


A partnership between the Center for Forensic Science Research and Education (CFSRE) and the Philadelphia Department of Public Health (PDPH) has been established to accurately assess the drug supply in Philadelphia, Pennsylvania. This initiative was established as a comprehensive effort. Select drug testing results from samples obtained within the city were compiled for preparation of this report. The results reported herein may not represent the entirety of the drug supply. The Drug Supply Assessment is intended to help promote timely and appropriate public health and public safety preparedness and response.

Summary and Key Findings:
▪ Reporting period: November 2020 to February 2021
▪ All “heroin” samples contained fentanyl cut with xylazine
▪ Counterfeit or disguised pills and tablets contained various unexpected synthetic drugs (e.g., NPS)
para-Fluorofentanyl is increasing among the drug supply


National Association of Drug Diversion Investigators Federal Tax ID: 52-1660752 / DUNS Number: 073539913

Copyright © 2021 - NADDI. All Rights Reserved. Privacy Policy / Trademark Policy / Copyright Policy / Refund Policy

Log in with your credentials


Forgot your details?

Create Account